Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma <br>CIRB: Adult CIRB - Late Phase EmphasisLead Group: RTOGStatus: ActiveReview Status: Available to Open
